Molecular Code-Breakers: How Generative AI is Rewriting India’s ₹1.5 Lakh Crore Antibiotic Playbook
India is pivoting its ₹1.5 lakh crore pharmaceutical engine toward AI-driven drug discovery to defeat global superbugs. By merging Nvidia-powered computing with sovereign data, the nation is moving from generic manufacturing to high-value IP creation.

